Skip to main content
. 2022 Oct 20;11(12):1405–1418. doi: 10.1002/cpdd.1183

Figure 2.

Figure 2

Mean plasma concentrations of netupitant over 12 and 120 hours after IV infusion of 17.6–176 mg fosnetupitant (A) and 212–353 mg fosnetupitant (SAD‐CO and P‐CO) or oral administration of netupitant 300 mg/palonosetron 0.5 mg (B). IV, intravenous; P‐CO, pilot crossover; SAD‐CO, single‐ascending‐dose crossover.